SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001491487-12-000017
Filing Date
2012-05-17
Accepted
2012-05-16 17:47:46
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 cmi033112q.htm 10-Q 280471
2 exhibit31.htm EX-31 6623
3 exhibit32.htm EX-31 6502
  Complete submission text file 0001491487-12-000017.txt   1037489

Data Files

Seq Description Document Type Size
4 cmi-20120331.xml EX-101.INS 55996
5 cmi-20120331.xsd EX-101.SCH 9856
6 cmi-20120331_cal.xml EX-101.CAL 5202
7 cmi-20120331_def.xml EX-101.DEF 38264
8 cmi-20120331_lab.xml EX-101.LAB 73661
9 cmi-20120331_pre.xml EX-101.PRE 52330
10 us-gaap-all-2012-01-31.xsd EX-101.SCH 2671
Mailing Address 1500 ROSECRANS AVENUE, SUITE 500 MANHATTAN BEACH CA 90266
Business Address 1500 ROSECRANS AVENUE, SUITE 500 MANHATTAN BEACH CA 90266 310-421-8654
Cardigant Medical Inc. (Filer) CIK: 0001491487 (see all company filings)

IRS No.: 264731758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-176329 | Film No.: 12849841
SIC: 2836 Biological Products, (No Diagnostic Substances)